Bill > A02327

This bill requires health care plans and utilization review agents in New York to provide more transparent reporting and public disclosure about step therapy override requests. Step therapy is a process where insurers require patients to try lower-cost medications before approving more expensive treatments. Specifically, the bill mandates that these organizations must annually report and publicly disclose detailed information about step therapy override requests, including the number of requests received, the types of healthcare providers submitting requests, the number of requests initially denied or approved, and the reasons for denials. This information must be reported to state departments and published on websites accessible to the public, organized by individual drug names and drug categories. Additionally, the bill requires insurers to update their websites when implementing new step therapy protocols and provide at least 60 days' notice to patients and healthcare professionals about any changes to these protocols. The goal is to increase transparency and help patients and providers better understand the step therapy approval process.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A2327